New York, NY, United States of America

Carmine Fedele

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carmine Fedele: Innovator in Antibody Research

Introduction

Carmine Fedele is a notable inventor based in New York, NY (US). He has made significant contributions to the field of antibody research, particularly in the development of compositions and methods that enhance therapeutic applications.

Latest Patents

Carmine Fedele holds a patent for "Compositions and methods comprising antibodies that bind to covalent peptide conjugates." This patent provides compositions and methods that include binding partners with specificity to target sites on proteins or peptides that comprise a covalently attached molecule. The binding partners are presented as antibodies and antibody derivatives that specifically bind to proteins and peptides modified by the attachment of a molecule, such as a drug. These binding partners can bind with specificity to covalently modified peptides when presented in the context of a major histocompatibility complex (MHC). The patent also outlines uses of these compositions and methods for the prophylaxis or therapy of various disorders.

Career Highlights

Carmine Fedele is affiliated with New York University, where he continues to advance his research in the field of antibody technology. His work has implications for improving therapeutic strategies in medicine.

Collaborations

Carmine has collaborated with notable colleagues, including Shohei Koide and Benjamin Neel, contributing to a dynamic research environment that fosters innovation.

Conclusion

Carmine Fedele's work in antibody research exemplifies the intersection of innovation and therapeutic application. His contributions are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…